Listed

Nephros Inc: Form 10-K for the period ended Dec 31, 2020

Filed with the SEC on Mar 1, 2021 and accepted by EDGAR at Mar 1, 2021, 16:16 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2020-01-01 to 2020-12-31$8.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue12 months2020-01-01 to 2020-12-31$3.6mus-gaap:CostOfGoodsAndServicesSold
Gross profit12 months2020-01-01 to 2020-12-31$4.9mus-gaap:GrossProfit
Research and development12 months2020-01-01 to 2020-12-31$2.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative12 months2020-01-01 to 2020-12-31$6.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income12 months2020-01-01 to 2020-12-31−$4.3mus-gaap:OperatingIncomeLoss
Interest expense12 months2020-01-01 to 2020-12-31$110.0kus-gaap:InterestExpense
Net income12 months2020-01-01 to 2020-12-31−$4.5mus-gaap:NetIncomeLoss
Diluted EPS12 months2020-01-01 to 2020-12-31−$0.52us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow12 months2020-01-01 to 2020-12-31−$6.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2020-01-01 to 2020-12-31$239.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2020-12-31$8.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$15.2mus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$18.5mus-gaap:Assets
Current liabilitiesAt period end2020-12-31$1.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-12-31$2.9mus-gaap:Liabilities
Long-term debtAt period end2020-12-31$593.0kus-gaap:LongTermDebt
Shareholders' equityAt period end2020-12-31$12.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-21-005090. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.